Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.170
+0.020 (1.74%)
At close: Aug 19, 2026, 4:00 PM EDT
1.190
+0.020 (1.71%)
After-hours: Aug 19, 2026, 4:17 PM EDT
Pliant Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Pliant Therapeutics stock has a consensus rating of "Hold" and an average price target of $2.50. The average 1-year stock price forecast is 113.68% higher than the current stock price, while the lowest is $2.00 (+70.94%) and the highest is $3.00 (+156.41%).
Price Target: $2.50 (+113.68%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Pliant Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 6 | 6 | 5 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 7 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Aug 18, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Reiterates $3 | Hold | Reiterates | $3 | +156.41% | Aug 13, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 13, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $2 | Hold | Maintains | $2 | +70.94% | Aug 12, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
3.00M
EPS This Year
-1.46
from -2.40
EPS Next Year
-1.33
from -1.46
EPS and Forward PE are based on non-GAAP adjusted numbers.